Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again
Investor's Business DailyGilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
The post Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again appeared first on Investor's Business Daily.